EP Patent

EP3999058A4 — TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN

Assigned to ARx LLC · Expires 2023-05-03 · 3y expired

What this patent protects

Patent listed against chembl-chembl2106195.

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3999058A4
Jurisdiction: EP
Classification: —
Expires: 2023-05-03
Drug substance claim: No
Drug product claim: No
Assignee: ARx LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.